Phreesia, Inc. (NYSE:PHR) Receives Consensus Rating of “Hold” from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned an average recommendation of “Hold” from the nineteen brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and nine have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $16.6471.

Several analysts recently commented on the company. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $9.00 price objective (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Piper Sandler downgraded shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price for the company. in a report on Thursday, May 28th. Citigroup restated a “market perform” rating on shares of Phreesia in a research report on Friday, May 29th. Finally, Canaccord Genuity Group decreased their price objective on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, May 28th.

Phreesia Stock Up 0.3%

PHR stock opened at $12.00 on Friday. The company has a market cap of $741.74 million, a PE ratio of 80.00 and a beta of 0.85. The business’s 50-day simple moving average is $10.72 and its 200 day simple moving average is $10.52. Phreesia has a twelve month low of $7.77 and a twelve month high of $32.76. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The firm had revenue of $130.94 million during the quarter, compared to analyst estimates of $130.08 million. During the same period in the prior year, the company posted ($0.07) earnings per share. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. On average, research analysts anticipate that Phreesia will post 0.39 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Royal Bank of Canada lifted its stake in shares of Phreesia by 208.8% in the first quarter. Royal Bank of Canada now owns 24,119 shares of the company’s stock valued at $617,000 after buying an additional 16,309 shares in the last quarter. AQR Capital Management LLC lifted its holdings in Phreesia by 471.2% during the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company’s stock worth $4,090,000 after acquiring an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company’s stock worth $1,599,000 after buying an additional 2,158 shares during the last quarter. NewEdge Advisors LLC grew its position in shares of Phreesia by 262.7% during the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company’s stock valued at $395,000 after acquiring an additional 11,181 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in Phreesia by 0.4% in the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company’s stock worth $15,336,000 after buying an additional 2,402 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.